Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. CLS Holdings USA's annualizedGross Profit for the quarter that ended in Feb. 2024 was $8.51 Mil.
CLS Holdings USA's average Total Assets over the quarter that ended in Feb. 2024 was $9.91 Mil. Therefore, CLS Holdings USA's annualized Gross-Profit-to-Asset % for the quarter that ended in Feb. 2024 was 85.84%.
CLS Holdings USA Gross-Profit-to-Asset % Historical Data
The historical data trend for CLS Holdings USA's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CLS Holdings USA's Gross-Profit-to-Asset %
For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CLS Holdings USA's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where CLS Holdings USA's Gross-Profit-to-Asset % falls into.
CLS Holdings USA Gross-Profit-to-Asset % Calculation
CLS Holdings USA's annualized Gross-Profit-to-Asset % for the fiscal year that ended in May. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Feb. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
CLS Holdings USA Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of CLS Holdings USA's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
CLS Holdings USA (CLS Holdings USA) Business Description
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLSH has been successfully added to your 